Mechanism of the luminol-dependent chemiluminescence of human neutrophils.

Lawrence R. DeChatelet, G D Long, Pamela S. Shirley, +4

The Journal of Immunology

Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: Results of a prospective double-blind randomized trial

Nelson J. Chao, DS Snyder, Maneesh Jain, +22

Biology of Blood and Marrow Transplantation

Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.

Sandra J. Horning, Robert S. Negrin, J. Chao, +3

Journal of Clinical Oncology

Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies.

C. Kusnierz-Glaz, P G Schlegel, R M Wong, +8

Journal of Clinical Oncology

Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia.

Margaret O’Donnell, G D Long, Pablo Parker, +7

Journal of Clinical Oncology

Prognostic and Predictive Factors for Patients With Metastatic Breast Cancer Undergoing Aggressive Induction Therapy Followed by High-Dose Chemotherapy With Autologous Stem-Cell Support

David A. Rizzieri, James J. Vredenburgh, Roy B. Jones, +14

Journal of Clinical Oncology

High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma

Joseph Alvarnas, Robert S. Negrin, Sandra J. Horning, +8

Biology of Blood and Marrow Transplantation

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment

Junya Kanda, Leylagül Kaynar, Yoshinobu Kanda, +15

Bone Marrow Transplantation

TransplantationMarrow TransplantationPre-engraftment SyndromeStem Cell TransplantationHematology +8

Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration

Mitchell E. Horwitz, John P. Chute, Christina Gasparetto, +6

Bone Marrow Transplantation

Induced Pluripotent Stem CellMedicineStem Cell MobilizationStem CellsPreemptive Dosing +6

Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection

Brian J. Byrne, Mitchell E. Horwitz, G D Long, +5

Bone Marrow Transplantation

Transplant RejectionTransplantationMarrow TransplantationStem Cell TransplantationHematology +5